In the past 20 years, the incidences of fungal infections, particularly opportunistic fungal infections, have significantly increased owing to the introduction of organ transplantation and cancer chemotherapy, and prevalence of AIDS [15, 18] . Less pathogenic species of Candida such as Candida dubliniensis and Saccharomyces cerevisiae, previously considered as clinically insignificant, are emerging as opportunistic pathogens affecting a variety of different body sites [5, 8, 10 ]. An outbreak of meningitis due to the zoonotic fungus Cryptococcus neoformans on the east coast of Vancouver Island in Canada attracted public attention in the year 2000 because this strain causes life-threatening meningocephalitis in immunocompromised and immunocompetent individuals [9, 12] . However, most available antifungal compounds exhibit high toxicity and various harmful effects on human cells; moreover, pathogenic fungi are resistant to these antifungal compounds. Therefore, demand for the development of novel antifungal agents that have few side effects and a broad-spectrum activity against various fungi is greater than ever before.
C. neoformans, a group of ubiquitous human and animal pathogen, is widely distributed in the environment and commonly isolated from avian excreta, soil, and trees. Disease is thought to progress upon inhalation of its basidiospores into the lungs, and then spreads from the lungs to the central nervous system to cause meningoencephalitis [17] .
Harrisonia abyssinica Oliv. (Simaroubaceae) is a small tree or shrub widely used in African folk remedies for the treatment of gonorrhea, dysentery, skin diseases, fever, bubonic plague, hemorrhoids, snakebite, and tuberculosis [1, 16] . The extracts of the bark and root of H. abyssinica have been found to exhibit in vitro antimicrobial, cytotoxic, insect antifeedant, antiviral, and molluscicidal activities [1, 16] , and stimulatory effects on Striga hermonthica seeds [2] . Various steroids, limonoids, chromone [2, 3, 14] , and
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Keywords: Signaling pathway, Cryptococcus neoformans, two-component system, calcineurin inhibitor, antifungal activity prenylated polyketides [2] have been isolated from H. abyssinica, and a very recent study showed that the novel prenylated acetophenones, harronin I and harronin II, isolated from this plant have potent antibacterial and antifungal activities [13] .
In the course of searching for fungal signaling modulators derived from plant extracts, calcineurin inhibitors of C. neoformans were found in the methanol extract of the whole body of H. abyssinica Oliv. Although H. abyssinica extract has been recognized as a useful folk remedy in Africa, there are no reports to date that suggest that the extract can be used as a specific inhibitor of the signaling pathway of C. neoformans by targeting calcineurin. Here, we describe the isolation and structure determination of two tannin compounds, chebulagic acid and chebulanin, and their inhibitory activities against various human fungi.
In order to discover and develop novel signaling modulators derived from plant extracts, we established a screening system for signaling modulators targeting the two-component system of wild-type C. neoformans var. grubii H99 and a calcineurin mutant cna1 of the C. neoformans H99 strain, based on the counter-regulatory action of highosmolarity glycerol (Hog1) mitogen-activated protein kinase (MAPK) and the calcineurin pathways in C. neoformans [11] .
C. neoformans var. grubii H99 (MATα) and C. neoformans cna1 (MATα cna1∆::NAT-STM#117) mutant strains [11] were cultured on YPD (1% yeast extract, 2% peptone, and 2% dextrose) medium at 30°C, and various human pathogenic fungi were cultured in Sabouraud broth (Difco) at 30°C for 24 h. The discovery of signaling modulators against C. neoformans was performed using the agar diffusion method [6] . The agar plates for the bioassay were prepared as two separate layers. The C. neoformans H99 and cna1 mutant suspensions were added into the overlay media containing 0.8% YPD agar. The base media with solidified YPD agar were then overlaid with each medium containing the C. neoformans H99 or cna1 mutant strains. After solidification of the overlay media, the two plates seeded with each strain were used in bioassays as follows. The A plate (known antifungal agent): C. neoformans H99 plus test sample; B plate (calcineurin inhibitor): C. neoformans H99 plus sample and fludioxonil; C plate (Hog1 inhibitor): C. neoformans cna1 mutant plus test sample and fludioxonil; D plate (Hog1 activator): C. neoformans cna1 mutant plus test sample. Sterile paper disks (8 mm in diameter) were placed on the surface of the four agar plates seeded with the C. neoformans H99 and cna1 mutant strains. Aliquots of the test samples with or without fludioxonil, which is a known Hog 1 activator [11] , were loaded onto the paper disks and incubated for 24 h at 30°C. The diameters of the inhibitory In addition, the minimum inhibitory concentrations (MICs) of the isolated compounds against various human pathogenic fungi were determined using the broth dilution method of the Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) [4] .
Large-scale screening of signaling pathway modulators was performed using 10,000 foreign plant extracts supplied by the International Biological Material Research Center (IMBRC), Korea Research Institute of Bioscience and Biotechnology. The change in the inhibition zone of the same sample on the four bioassay plates containing wild type and a calcineurin mutant of C. neoformans was analyzed with the naked eye in comparison with the control compound, fludioxonil; three candidates showing inhibitory activities only on B or C plate were selected from the 10,000 plant extracts. Among these, bioactive compounds from H. abyssinica Oliv. with a clear zone only on the B plate were isolated and purified using ethyl acetate extraction, silica gel column chromatography, Sephadex-LH20 column chromatography, thin-layer chromatography, and highperformance liquid chromatography (HPLC). The retention times of the purified bioactive compounds in an HPLC analysis were 19.5 and 16.8 min (Fig. 1) . Structural analyses of the isolated compounds with electrospray ionization mass spectrometry (ESI-MS) and various nuclear magnetic resonance (NMR) techniques, including
HMQC, DEPT, and HMBC, revealed that these compounds had the molecular formulas C 41 H 30 O 27 and C 27 H 24 O 19 with molecular weights of 954 and 652, respectively (Fig. 2) . Based on the data, these compounds were identified as chebulagic acid and chebulanin ( '-H) . The MS and NMR data for the purified compounds were in good agreement with the spectral data for both compounds previously published [7] . The antifungal activities of the isolated chebulagic acid and chebulanin against human pathogenic fungi were determined by MIC evaluations using the broth dilution method of the CLSI. Chebulagic acid showed potent antifungal activities against various human pathogenic fungi, such as C. albicans, C. krusei, C. lusitaniae, C. tropicalis, C. neoformans, and C. neoformans var. grubii, with MICs of 0.25-4 µg/ml. The strongest antifungal activities were noted against C. neoformans and C. lusitaniae at concentrations of 0.25 and 0.5 µg/ml, respectively, whereas relatively weak antifungal activities against A. fumigatus and Trichophyton mentagrophytes were observed (Table 1) . Chebulanin also showed potent antifungal activities against C. neoformans, C. lusitaniae, and C. neoformans var. grubii, albeit weaker than that of chebulagic acid.
Although a number of compounds isolated from H. abyssinica Oliv. have been reported [2, 3, 13, 14] , only limited information is available on their biological activities. In particular, little is known of the in vitro antifungal activities of tannin compounds against various human pathogenic fungi. Taken together, this is the first report that chebulagic acid and chebulanin inhibited a calcineurin pathway of C. neoformans and showed potent antifungal activities in vitro against human pathogenic fungi. Therefore, chebulagic acid and chebulanin may serve as lead compounds for the development of inhibitors of the signaling pathway 
